×
  • Category
  • Type
  • Advanced

PAHO Revolving Fund

Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030

Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches

The economic burden of measles in children under five in Bangladesh

The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks

MI4A Vaccine Purchase Data for Countries - 2020

Using PATH’s Vaccine Cost Calculators to inform immunization decision-making

Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program

The cost of routine immunization outreach in the context of COVID-19: estimates from Tanzania and Indonesia

Estimating the additional cost for maintaining facility-based Routine Immunization programs in the context of COVID-19

Pneumococcal Conjugate Vaccine Cost Calculator

Rotavirus Vaccine Cost Calculator

The economic burden of measles in children under five in Uganda

Programmatic and financial benefits of establishing an effective temperature monitoring system in the vaccines supply chain - case study in Cameroon

MI4A Vaccine Purchase Data for Countries - 2019

The BID Initiative: Total Cost of Ownership Tool

Increasing Access to Health Products in the DRC

WHO Cervical Cancer Prevention and Control Costing Tool (C4P)